177 related articles for article (PubMed ID: 29353249)
1. Plasma cell-free DNA methylation: a liquid biomarker of hepatic fibrosis.
Yiğit B; Boyle M; Özler O; Erden N; Tutucu F; Hardy T; Bergmann C; Distler JHW; Adalı G; Dayangaç M; Mann DA; Zeybel M; Mann J
Gut; 2018 Oct; 67(10):1907-1908. PubMed ID: 29353249
[No Abstract] [Full Text] [Related]
2. The gamma-glutamyl transpeptidase to platelet ratio for non-invasive assessment of liver fibrosis in patients with chronic hepatitis B and non-alcoholic fatty liver disease.
Li Q; Lu C; Li W; Huang Y; Chen L
Oncotarget; 2017 Apr; 8(17):28641-28649. PubMed ID: 28415736
[TBL] [Abstract][Full Text] [Related]
3. New insight of vitamin D in chronic liver diseases.
Chen EQ; Shi Y; Tang H
Hepatobiliary Pancreat Dis Int; 2014 Dec; 13(6):580-5. PubMed ID: 25475859
[TBL] [Abstract][Full Text] [Related]
4. Retrospective evaluation of serum markers APRI and AST/ALT for assessing liver fibrosis and cirrhosis in chronic hepatitis B and C patients with hepatocellular carcinoma.
Lin CS; Chang CS; Yang SS; Yeh HZ; Lin CW
Intern Med; 2008; 47(7):569-75. PubMed ID: 18379139
[TBL] [Abstract][Full Text] [Related]
5. Combined use of murine double minute-2 promoter methylation and serum AFP improves diagnostic efficiency in hepatitis B virus-related hepatocellular carcinoma.
Wang JW; Qian Y; Wu CS; Zhao NH; Fang Y; Yuan XD; Gao S; Fan YC; Wang K
Int J Med Sci; 2020; 17(18):3190-3199. PubMed ID: 33173438
[No Abstract] [Full Text] [Related]
6. Circulating Fatty Acids Associated with Advanced Liver Fibrosis and Hepatocellular Carcinoma in South Texas Hispanics.
Jiao J; Kwan SY; Sabotta CM; Tanaka H; Veillon L; Warmoes MO; Lorenzi PL; Wang Y; Wei P; Hawk ET; Almeda JL; McCormick JB; Fisher-Hoch SP; Beretta L
Cancer Epidemiol Biomarkers Prev; 2021 Sep; 30(9):1643-1651. PubMed ID: 34155064
[TBL] [Abstract][Full Text] [Related]
7. Connective tissue growth factor (CTGF/CCN2) in serum is an indicator of fibrogenic progression and malignant transformation in patients with chronic hepatitis B infection.
Gressner OA; Fang M; Li H; Lu LG; Gressner AM; Gao CF
Clin Chim Acta; 2013 Jun; 421():126-31. PubMed ID: 23501329
[TBL] [Abstract][Full Text] [Related]
8. Soluble fibrinogen-like protein 2 levels in patients with hepatitis B virus-related liver diseases.
Van Tong H; Van Ba N; Hoan NX; Binh MT; Quyen DT; Son HA; Van Luong H; Quyet D; Meyer CG; Song LH; Toan NL; Velavan TP
BMC Infect Dis; 2018 Nov; 18(1):553. PubMed ID: 30419833
[TBL] [Abstract][Full Text] [Related]
9. Methylated cysteine dioxygenase-1 gene promoter in the serum is a potential biomarker for hepatitis B virus-related hepatocellular carcinoma.
Yang Y; Fan YC; Gao S; Dou CY; Zhang JJ; Sun FK; Wang K
Tohoku J Exp Med; 2014 Mar; 232(3):187-94. PubMed ID: 24646840
[TBL] [Abstract][Full Text] [Related]
10. [N-glycomic changes in hepatocellular carcinoma patients with liver cirrhosis induced by hepatitis B virus].
Liu XE; Desmyter L; Gao CF; Laroy W; Dewaele S; Vanhooren V; Wang L; Zhuang H; Callewaert N; Libert C; Contreras R; Chen CY
Zhonghua Gan Zang Bing Za Zhi; 2008 Jan; 16(1):74-5. PubMed ID: 18226355
[No Abstract] [Full Text] [Related]
11. Sera DNA Methylation of CDH1, DNMT3b and ESR1 Promoters as Biomarker for the Early Diagnosis of Hepatitis B Virus-Related Hepatocellular Carcinoma.
Dou CY; Fan YC; Cao CJ; Yang Y; Wang K
Dig Dis Sci; 2016 Apr; 61(4):1130-8. PubMed ID: 26660680
[TBL] [Abstract][Full Text] [Related]
12. Expression of IL-17 and its gene promoter methylation status are associated with the progression of chronic hepatitis B virus infection.
Tian CH; Dai J; Zhang W; Liu Y; Yang Y
Medicine (Baltimore); 2019 Jun; 98(23):e15924. PubMed ID: 31169710
[TBL] [Abstract][Full Text] [Related]
13. Epigenetically-regulated serum GAS5 as a potential biomarker for patients with chronic hepatitis B virus infection.
Guo Y; Li C; Zhang R; Zhan Y; Yu J; Tu J; Zheng J
Cancer Biomark; 2021; 32(2):137-146. PubMed ID: 34092613
[TBL] [Abstract][Full Text] [Related]
14. Plasma DNA methylation: a potential biomarker for stratification of liver fibrosis in non-alcoholic fatty liver disease.
Hardy T; Zeybel M; Day CP; Dipper C; Masson S; McPherson S; Henderson E; Tiniakos D; White S; French J; Mann DA; Anstee QM; Mann J
Gut; 2017 Jul; 66(7):1321-1328. PubMed ID: 27002005
[TBL] [Abstract][Full Text] [Related]
15. Autoantibodies in Chinese patients with chronic hepatitis B: prevalence and clinical associations.
Li BA; Liu J; Hou J; Tang J; Zhang J; Xu J; Song YJ; Liu AX; Zhao J; Guo JX; Chen L; Wang H; Yang LH; Lu J; Mao YL
World J Gastroenterol; 2015 Jan; 21(1):283-91. PubMed ID: 25574103
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of serum clusterin as a surveillance tool for human hepatocellular carcinoma with hepatitis B virus related cirrhosis.
Wang Y; Liu YH; Mai SJ; He LJ; Liao YJ; Deng HX; Guan XY; Zeng YX; Kung HF; Xie D
J Gastroenterol Hepatol; 2010 Jun; 25(6):1123-8. PubMed ID: 20594228
[TBL] [Abstract][Full Text] [Related]
17. Albumin-Bilirubin Score Differentiates Liver Fibrosis Stage and Hepatocellular Carcinoma Incidence in Chronic Hepatitis B Virus Infection: A Retrospective Cohort Study.
Fujita K; Nomura T; Morishita A; Oura K; Yoneyama H; Kobara H; Tsutsui K; Himoto T; Masaki T
Am J Trop Med Hyg; 2019 Jul; 101(1):220-225. PubMed ID: 31115300
[TBL] [Abstract][Full Text] [Related]
18. Diverse Changes of Circulating Fibroblast Growth Factor 21 Levels in Hepatitis B Virus-Related Diseases.
Wu L; Pan Q; Wu G; Qian L; Zhang J; Zhang L; Fang Q; Zang G; Wang Y; Lau G; Li H; Jia W
Sci Rep; 2017 Nov; 7(1):16482. PubMed ID: 29184085
[TBL] [Abstract][Full Text] [Related]
19. Profiles of serum microRNAs; miR-125b-5p and miR223-3p serve as novel biomarkers for HBV-positive hepatocellular carcinoma.
Giray BG; Emekdas G; Tezcan S; Ulger M; Serin MS; Sezgin O; Altintas E; Tiftik EN
Mol Biol Rep; 2014 Jul; 41(7):4513-9. PubMed ID: 24595450
[TBL] [Abstract][Full Text] [Related]
20. Combined detection of AFP-L3, GP73 and TIP30 enhances diagnostic accuracy for HBV-related cirrhosis and hepatocellular carcinoma.
Yanming L; Yue C; Wencan C; Liangyin WU; Xijun L; Jiafeng Z; Fengping HE
J Pak Med Assoc; 2019 Sep; 69(9):1279-1286. PubMed ID: 31511712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]